Liraglutide attenuates autoimmune myocarditis by inhibiting NLRP3 and NF-κb pathways
Abstract Myocarditis, an inflammatory heart disease, often leads to severe cardiac dysfunction, including dilated cardiomyopathy and sudden death. Current treatments for myocarditis remain limited, necessitating the exploration of new therapeutic approaches. Liraglutide, a glucagon-like peptide-1 re...
Saved in:
| Main Authors: | Lijuan Zhang, Lishuai Han, Yang Lu, Quanzhou Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-12715-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TLR2 and NLRP3 Orchestrate Regulatory Roles in Escherichia coli Infection-Induced Septicemia in Mouse Models
by: Zhiguo Gong, et al.
Published: (2024-10-01) -
Research advances of role of TLR4/NLRP3 inflammasome in diabetic nephropathy
by: Deng Xuan, et al.
Published: (2022-07-01) -
LIRAGLUTIDE PLEIOTROPIC EFFECT IN CARDIOVASCULAR RISK REDUCTION IN TYPE 2 DIAbETES — A MANDATE FOR CARDIOLOGIST AND INTERNIST
by: S. V. Nedogoda
Published: (2018-05-01) -
Protective effects of liraglutide on hypercholesterolemia-associated atherosclerosis involve attenuation of endothelial-monocyte adhesion through down-regulating the LOX-1/NF-κB signaling pathway
by: Aiping Wu, et al.
Published: (2025-07-01) -
Prediction scale of response to liraglutide therapy as the method for increase of treatment efficacy in type 2 diabetes
by: Anna A Mosikian, et al.
Published: (2022-03-01)